Neurocritical Care

, Volume 15, Issue 1, pp 170–174 | Cite as

Cerebellar hemorrhage as a first presentation of acquired Hemophilia A

  • Dejan Micic
  • Eliot C. Williams
  • Joshua E. Medow
Practical Pearl



Acquired hemophilia A (AHA) is an uncommon coagulation disorder caused by the development of autoantibodies against coagulation factor VIII (FVIII). While intracranial hemorrhage is a known complication of AHA, intracranial hemorrhage as the presenting manifestation of AHA has only been described in three previous case reports.


We report a case of an 86-year-old woman with no previously reported history of coagulopathy presenting with an acute intraparenchymal cerebellar hemorrhage and laboratory studies demonstrating an isolated prolonged activated partial thromboplastin time (aPTT). We discuss an approach to the prolonged aPTT, and review the literature concerning the diagnosis and treatment of AHA.


Occipital decompressive craniectomy with evacuation of the hemorrhage was performed. Eight hours following the procedure, the patient’s status acutely declined with demonstration of a reoccurrence of the cerebellar hemorrhage and new right frontal lobe hemorrhage. After discussion with the patient’s family, life-sustaining support measures were withdrawn. Postmortem analysis revealed a low FVIII activity level and the presence of FVIII inhibitor.


The presentation of intracranial hemorrhage with an isolated prolonged aPTT is concerning for an acquired hemophilia with FVIII deficiency. Other causes of isolated prolonged aPTT such as a lupus anticoagulant must also be considered. Preoperative identification and work-up of the coagulation abnormality is essential to guide initial treatment.


Acquired hemophilia A Coagulation disorder aPTT Intraparenchymal hemorrhage FVIII rFVIIa Lupus anticoagulant 


  1. 1.
    Franchini M, Gandini G, Di Paolantonio T, Mariani G. Acquired hemophilia A: a concise review. Am J Hematol. 2005;80:55–63.PubMedCrossRefGoogle Scholar
  2. 2.
    Franchini M, Lippi G. Acquired factor VIII inhibitors. Blood. 2008;112:250–5.PubMedCrossRefGoogle Scholar
  3. 3.
    Bouvry P, Recloux P. Acquired hemophilia. Haematologica. 1994;79:550–6.PubMedGoogle Scholar
  4. 4.
    Mashiko R, Yamamoto T, Sato M, Noguchi S, Matsumura A. Acquired hemophilia first manifesting as life-threatening intracranial hemorrhage: case report. Neurol Med Chir (Tokyo). 2009;49:93–5.CrossRefGoogle Scholar
  5. 5.
    Bonnaud I, Saudeau D, de Toffol B, Autret A. Recurrence of spontaneous subdural haematoma revealing acquired haemophilia. Eur Neurol. 2003;49:253–4.PubMedCrossRefGoogle Scholar
  6. 6.
    Marquardt L, Haubelt H, Gass S, Grau AJ. Intracranial bleeding in acquired hemophilia. Nervenarzt. 2006;77:1480–2.PubMedCrossRefGoogle Scholar
  7. 7.
    Kamal AH, Tefferi A, Pruthi RK. How to interpret and pursue an abnormal prothrombin time, activated partial thromboplastin time, and bleeding time in adults. Mayo Clin Proc. 2007;82:864–73.PubMedCrossRefGoogle Scholar
  8. 8.
    Chng WJ, Sum C, Kuperan P. Causes of isolated prolonged activated partial thromboplastin time in an acute care general hospital. Singapore Med J. 2005;46:450–6.PubMedGoogle Scholar
  9. 9.
    Hay CR. Acquired haemophilia. Baillieres Clin Haematol. 1998;11:287–303.PubMedCrossRefGoogle Scholar
  10. 10.
    Hartmann M, Sucker C. Pharmacology and clinical use of recombinant activated factor seven in neurosciences. Neurocrit Care. 2007;6:149–57.PubMedCrossRefGoogle Scholar
  11. 11.
    Schmidt ML, Gamerman S, Smith HE, Scott JP, DiMichele DM. Recombinant activated factor VII (rFVIIa) therapy for intracranial hemorrhage in hemophilia A patients with inhibitors. Am J Hematol. 1994;47:36–40.PubMedCrossRefGoogle Scholar
  12. 12.
    Collins P, Baudo F, Huth-Kuhne A, et al. Consensus recommendations for the diagnosis and treatment of acquired hemophilia A. BMC Res Notes. 2010;3:161.PubMedCrossRefGoogle Scholar

Copyright information

© Springer Science+Business Media, LLC 2010

Authors and Affiliations

  • Dejan Micic
    • 1
  • Eliot C. Williams
    • 2
  • Joshua E. Medow
    • 3
  1. 1.University of Wisconsin School of Medicine and Public HealthMadisonUSA
  2. 2.Department of Internal Medicine, Section of HematologyUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA
  3. 3.Department of NeurosurgeryUniversity of Wisconsin School of Medicine and Public HealthMadisonUSA

Personalised recommendations